Simplex Trading’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-281
| Closed | -$529K | – | 8437 |
|
|
2019
Q3 | $529K | Buy |
281
+201
| +251% | +$2.3K | ﹤0.01% | 2565 |
|
|
2019
Q2 | $94K | Buy |
80
+72
| +900% | +$872 | ﹤0.01% | 4258 |
|
|
2019
Q1 | $10K | Sell |
8
-7
| -47% | -$91 | ﹤0.01% | 6180 |
|
|
2018
Q4 | $15K | Sell |
15
-99
| -87% | -$1.27K | ﹤0.01% | 5595 |
|
|
2018
Q3 | $189K | Sell |
114
-13
| -10% | -$235 | ﹤0.01% | 3704 |
|
|
2018
Q2 | $200K | Buy |
127
+103
| +429% | +$1.56K | ﹤0.01% | 3491 |
|
|
2018
Q1 | $7K | Sell |
24
-91
| -79% | -$1.32K | ﹤0.01% | 4413 |
|
|
2017
Q4 | $11K | Sell |
115
-77
| -40% | -$860 | ﹤0.01% | 3859 |
|
|
2017
Q3 | $26K | Sell |
192
-169
| -47% | -$1.76K | ﹤0.01% | 2929 |
|
|
2017
Q2 | $86K | Buy |
361
+352
| +3,911% | +$6.51K | ﹤0.01% | 1892 |
|
|
2017
Q1 | $3K | Sell |
9
-15
| -63% | -$332 | ﹤0.01% | 5147 |
|
|
2016
Q4 | $2K | Sell |
24
-16
| -40% | -$416 | ﹤0.01% | 5208 |
|
|
2016
Q3 | $3K | Buy |
40
+34
| +567% | +$1.03K | ﹤0.01% | 4805 |
|
|
2016
Q2 | $1K | Sell |
6
-250
| -98% | -$6.76K | ﹤0.01% | 5578 |
|
|
2016
Q1 | $56K | Buy |
256
+199
| +349% | +$4.61K | ﹤0.01% | 1874 |
|
|
2015
Q4 | $9K | Sell |
57
-353
| -86% | -$11.9K | ﹤0.01% | 3447 |
|
|
2015
Q3 | $196K | Buy |
410
+355
| +645% | +$15.1K | 0.01% | 928 |
|
|
2015
Q2 | $3K | Buy |
+55
| New | +$2K | ﹤0.01% | 4166 |
|
Simplex Trading's ALDR Position: Q4 2019 in Review
Simplex Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 12,198 shares — an estimated $230K sold.
Simplex Trading first reported a position in ALDR in Q2 2015 and held it in 16 quarters. The position peaked at $764K in Q3 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Simplex Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Simplex Trading sold 12,198 Alder Biopharmaceuticals shares in Q4 2019, an estimated $230K.
- Simplex Trading first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 16 quarters.
- Simplex Trading's Alder Biopharmaceuticals position peaked at $764K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.